Solara Active gets EIR from USFDA for Mangalore facility
Solara Active Pharma Sciences has completed USFDA inspection at its multi-product API facility in Mangalore. As part of GMP compliance audit, the company has received Establishment Inspection Report (EIR) from USFDA, thereby confirming the closure of the inspection in July 2018. Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. … Read more